HPV+ cervical cancer patients display cancer cell upregulation of the surface MHC class-I molecule HLA-C as well as the corresponding NK cell surface markers KIR2DL2 and KIR2DL3 (13). The gene discussed is KIR2DL3; the disease is cervical carcinoma.